Why this listing is (still) the shortest path to approval
Heart transplantation is the final‐stage treatment for otherwise fatal cardiomyopathies and ischemic heart disease. Because post-surgical recovery is universally arduous—immunosuppression, infection risk, graft-vasculopathy surveillance—SSA grants an automatic one-year presumption of disability. Your chief task is therefore administrative: prove the transplant date, secure a full year of benefits, and, before that year lapses, build the record that will keep your client on benefits under an appropriate residual listing (usually 4.02 or 4.04) or under a residual functional-capacity (RFC) analysis.
Full regulatory text
“4.09 Heart transplant.
We will consider you disabled for 1 year following the date of the heart transplant. After that, we will evaluate any residual impairment under the appropriate listing.”
(20 C.F.R. Pt 404, Subpt P, App. 1, § 4.09.)
Element-by-element (mercifully brief)
| Requirement | Proof | Typical sources |
|---|---|---|
| Heart transplant performed | Operative report or hospital discharge summary stating orthotopic or heterotopic transplant | Transplant-center records (e.g., Cleveland Clinic, Mayo, Columbia) |
| Date of surgery | Same documents; must be clear and legible | Include cover letter noting exact date |
| Evidence of ongoing management (not required to meet listing but crucial for post-year evaluation) | Post-transplant clinic notes, endomyocardial‐biopsy reports, echocardiograms, medication lists | Transplant cardiology follow-up; pharmacy fills (tacrolimus, mycophenolate, prednisone) |
Practical tips for airtight approval
- File immediately after surgery
Do not wait for the six-month post-op milestone; the listing starts counting on the surgery date. - Send the operative note with the application or appeal
DDS can rarely obtain transplant records quickly. Supplying the note speeds allowance. - Flag immunosuppressive side effects
Nephrotoxicity, tremor, diabetes, opportunistic infections—all help justify continuing disability after the one-year window. - Prepare for the second-look review
SSA will diary the case for medical improvement at month 12. Before that date, collect:
• Latest ejection-fraction (echo, MUGA)
• Evidence of cardiac allograft vasculopathy (CAV) from coronary angiography or IVUS
• Renal labs (creatinine rise from calcineurin inhibitors)
• Infectious or oncologic complications (CMV, PTLD)
Tie the findings to Listing 4.02 (chronic heart failure) or 4.12 (peripheral arterial disease if CAV is severe), or craft an RFC limiting exposure to infection, temperature extremes, and exertion > 3 METs. - Address graft-rejection episodes
Acute‐cellular or antibody-mediated rejection requiring IV steroids/plasmapheresis counts as “episodes of decompensation.” Cite them in any post-year argument.
Professional bottom line
Listing 4.09 grants an automatic twelve-month disability period beginning on the transplant date. Submit the operative report up front, ensure meticulous documentation of post-transplant complications, and—well before the diary date—re-map the client’s residual cardiac and systemic problems to another listing or to an RFC that precludes competitive employment. Done correctly, the transplant becomes not just a medical lifesaver but a procedural fast-track to long-term benefit security.
Under Listing 4.09, a Social Security Disability Lawyer can help secure the transplant operative report, confirm the exact surgery date, and organize post-operative records to ensure the automatic 12-month period of disability is properly awarded. As the review period approaches, additional documentation of graft function, immunosuppressive complications, and cardiac follow-up testing becomes essential to transition the claim into continued eligibility under related cardiac listings or an RFC-based approval.